SPDR S&P Biotech ETF (NYSEARCA:XBI) Stock Position Trimmed by Financial Advocates Investment Management

Financial Advocates Investment Management trimmed its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 69.1% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 3,699 shares of the exchange traded fund’s stock after selling 8,269 shares during the period. Financial Advocates Investment Management’s holdings in SPDR S&P Biotech ETF were worth $333,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Avior Wealth Management LLC grew its position in SPDR S&P Biotech ETF by 393.6% in the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after buying an additional 307 shares in the last quarter. Tidemark LLC lifted its stake in shares of SPDR S&P Biotech ETF by 101.5% in the 3rd quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock worth $39,000 after acquiring an additional 199 shares during the period. Quintet Private Bank Europe S.A. bought a new position in shares of SPDR S&P Biotech ETF in the third quarter valued at approximately $40,000. ORG Wealth Partners LLC acquired a new position in shares of SPDR S&P Biotech ETF during the third quarter valued at approximately $44,000. Finally, Howe & Rusling Inc. bought a new stake in SPDR S&P Biotech ETF during the third quarter worth approximately $49,000.

SPDR S&P Biotech ETF Stock Performance

Shares of NYSEARCA XBI opened at $91.24 on Monday. SPDR S&P Biotech ETF has a 1 year low of $81.14 and a 1 year high of $105.47. The firm has a market cap of $6.95 billion, a P/E ratio of 11.47 and a beta of 1.11. The stock has a fifty day moving average price of $92.58 and a two-hundred day moving average price of $96.46.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.